We narrowed to 148 results for: GFP expression plasmids

1. pAAV-S5E2-GFP-fGFP (AAV9)

   Viral Prep

   #135631-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EGFP

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-S5E2-GFP-fGFP (AAV1)

   Viral Prep

   #135631-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EGFP

   Available Since

   Sept. 15, 2021

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-S5E2-GFP-fGFP (AAV PHP.eB)

   Viral Prep

   #135631-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-GFP-fGFP (#135631). In addition to the viral particles, you will also receive purified pAAV-S5E2-GFP-fGFP plasmid DNA. Bicistronic expression of GFP and membrane-targeted GFP under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EGFP

   Available Since

   Nov. 29, 2021

   Availability

   Academic Institutions and Nonprofits only

4. pAAV.GfaABC1D.PI.Lck-GFP.SV40 (AAV5)

   Viral Prep

   #105598-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV.GfaABC1D.PI.Lck-GFP.SV40 (#105598). In addition to the viral particles, you will also receive purified pAAV.GfaABC1D.PI.Lck-GFP.SV40 plasmid DNA. GfaABC1D-driven GFP expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Baljit Khakh

   Article

   Shigetomi et al J Gen Physiol. 2013 Apr 15.

   Promoter

   GfaABC1D

   Tags

   GFP

   Available Since

   March 8, 2018

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.TBG.PI.eGFP.WPRE.bGH (AAV8)

   Viral Prep

   #105535-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV.TBG.PI.eGFP.WPRE.bGH (#105535). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.eGFP.WPRE.bGH plasmid DNA. TBG-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   TBG

   Tags

   EGFP

   Available Since

   April 30, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pENN.AAV.EF1a.eGFP.WPRE.rBG (AAV1)

   Viral Prep

   #105547-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pENN.AAV.EF1a.eGFP.WPRE.rBG (#105547). In addition to the viral particles, you will also receive purified pENN.AAV.EF1a.eGFP.WPRE.rBG plasmid DNA. EF1a-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   EF1a

   Tags

   EGFP

   Available Since

   Sept. 13, 2021

   Availability

   Academic Institutions and Nonprofits only

7. pAAV.GFAP.eGFP.WPRE.hGH (AAV5)

   Viral Prep

   #105549-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV.GFAP.eGFP.WPRE.hGH (#105549). In addition to the viral particles, you will also receive purified pAAV.GFAP.eGFP.WPRE.hGH plasmid DNA. GFAP-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   GFAP

   Tags

   EGFP

   Available Since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

8. pAAV.hSyn.eGFP.WPRE.bGH (AAV1)

   Viral Prep

   #105539-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV.hSyn.eGFP.WPRE.bGH (#105539). In addition to the viral particles, you will also receive purified pAAV.hSyn.eGFP.WPRE.bGH plasmid DNA. Synapsin-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   Syn

   Tags

   EGFP

   Available Since

   July 23, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pENN.AAV.EF1a.eGFP.WPRE.rBG (AAV2)

   Viral Prep

   #105547-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pENN.AAV.EF1a.eGFP.WPRE.rBG (#105547). In addition to the viral particles, you will also receive purified pENN.AAV.EF1a.eGFP.WPRE.rBG plasmid DNA. EF1a-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   EF1a

   Tags

   EGFP

   Available Since

   Oct. 18, 2021

   Availability

   Academic Institutions and Nonprofits only

10. pENN.AAV.EF1a.eGFP.WPRE.rBG (AAV8)

    Viral Prep

    #105547-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pENN.AAV.EF1a.eGFP.WPRE.rBG (#105547). In addition to the viral particles, you will also receive purified pENN.AAV.EF1a.eGFP.WPRE.rBG plasmid DNA. EF1a-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    James M. Wilson

    Promoter

    EF1a

    Tags

    EGFP

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only